Noah Gaarder-Feingold represents public and private companies across a range of corporate matters, including public offerings, private financings, M&A and general corporate governance.
Download full bio
Ambrx Biopharma – $126 Million IPO
Reneo Pharmaceuticals – $94 Million IPO
Mergers & Acquisitions
University of San Diego, School of LawJD, summa cum laude, Order of the Coif, 2020
University of California, Los AngelesBA, Filmcum laude, 2013
+1 (858) 550-6153